| Name | 5β-androst-9(11)-ene-3,17-dione |
|---|---|
| Synonyms |
(5R,8S,10S,13S,14S)-10,13-Dimethyl-5,6,7,8,10,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,4H)-dione
5β-Androstene- 9, 11-ene 3, 17- Dione )-Androst-9(11)-ene-3,17-dione 5beta-androst-9(11)-ene-3,17-dione (5β)-Androst-9-ene-3,17-dione Androst-9(11)-ene-3,17-dione, (5β) (5Beta)-Androst-9-ene-3,17-dione (5β)-Androst-9(11)-ene-3,17-dione |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 424.8±45.0 °C at 760 mmHg |
| Molecular Formula | C19H26O2 |
| Molecular Weight | 286.409 |
| Flash Point | 158.8±25.7 °C |
| Exact Mass | 286.193268 |
| PSA | 34.14000 |
| LogP | 3.07 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.552 |
|
~98%
1093397-63-7 |
| Literature: KYTHERA BIOPHARMACEUTICALS, INC.; MORIARTY, Robert M.; PRASAD, Achampeta Rathan; REID, John Gregory; SWARINGEN Jr., Roy A. Patent: WO2011/75701 A2, 2011 ; Location in patent: Page/Page column 77-78, 103-104, 125-126 ; |
| Precursor 1 | |
|---|---|
| DownStream 4 | |